NasdaqGS - Delayed Quote • USD
Repligen Corporation (RGEN)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 4:03 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 12 | 12 | 12 | 11 |
| Avg. Estimate | 0.3 | 0.33 | 1.46 | 2.05 |
| Low Estimate | 0.27 | 0.29 | 1.44 | 1.85 |
| High Estimate | 0.34 | 0.37 | 1.49 | 2.35 |
| Year Ago EPS | 0.64 | 0.53 | 1.75 | 1.46 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 12 | 12 | 12 | 11 |
| Avg. Estimate | 150.06M | 153.72M | 635.64M | 734.62M |
| Low Estimate | 146M | 149.96M | 628M | 718M |
| High Estimate | 154.64M | 156.5M | 644.4M | 751.68M |
| Year Ago Sales | 182.66M | -- | 638.76M | 635.64M |
| Sales Growth (year/est) | -17.80% | -- | -0.50% | 15.60% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | 0.59 | 0.47 | 0.17 | 0.33 |
| EPS Actual | 0.64 | 0.53 | 0.23 | 0.33 |
| Difference | 0.05 | 0.06 | 0.06 | 0 |
| Surprise % | 8.50% | 12.80% | 35.30% | 0.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0.3 | 0.33 | 1.46 | 2.05 |
| 7 Days Ago | 0.3 | 0.33 | 1.46 | 2.07 |
| 30 Days Ago | 0.3 | 0.33 | 1.45 | 2.08 |
| 60 Days Ago | 0.29 | 0.34 | 1.47 | 2.07 |
| 90 Days Ago | 0.36 | 0.41 | 1.77 | 2.61 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | 1 | 1 | 1 | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | 1 |
Growth Estimates
| CURRENCY IN USD | RGEN | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -53.10% | -- | -- | 6.50% |
| Next Qtr. | -37.70% | -- | -- | 12.00% |
| Current Year | -16.60% | -- | -- | 5.30% |
| Next Year | 40.40% | -- | -- | 13.10% |
| Next 5 Years (per annum) | 17.96% | -- | -- | 11.09% |
| Past 5 Years (per annum) | 17.90% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | Stifel: Buy to Buy | 2/22/2024 |
| Maintains | Keybanc: Overweight to Overweight | 2/15/2024 |
| Maintains | JP Morgan: Overweight to Overweight | 12/20/2023 |
| Downgrade | Benchmark: Buy to Hold | 12/4/2023 |
| Maintains | UBS: Buy to Buy | 11/2/2023 |
| Maintains | Stifel: Buy to Buy | 11/1/2023 |
Related Tickers
RMD ResMed Inc.
218.06
+18.89%
WST West Pharmaceutical Services, Inc.
360.43
-2.10%
STAA STAAR Surgical Company
46.96
+0.15%
STVN Stevanato Group S.p.A.
27.54
+0.07%
COO The Cooper Companies, Inc.
88.84
-1.21%
ISRG Intuitive Surgical, Inc.
375.33
+0.59%
HOLX Hologic, Inc.
75.98
+0.36%
ATR AptarGroup, Inc.
143.33
+2.25%
ICUI ICU Medical, Inc.
94.84
+0.33%
TFX Teleflex Incorporated
206.71
0.00%